SynthesisFrontiers in pharmacology2026
The clinical trial landscape of bispecific antibodies in non-small cell lung cancer: mechanistic trends and developmental strategies.
Zunyuan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.